Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 3, 2008, Pages

  Makita, Ryosuke ^a   Uchijima, Yasunobu ^a   Nishiyama, Koichi ^a   Amano, Tomokazu ^a   Chen, Qin ^a   Takeuchi, Takumi ^a   Mitani, Akihisa ^a   Nagase, Takahide ^a   Yatomi, Yutaka ^a   Aburatani, Hiroyuki ^b   Nakagawa, Osamu ^c,d   Small, Erin V ^c   Cobo Stark, Patricia ^c   Igarashi, Peter ^c   Murakami, Masao ^a,e   Tominaga, Junji ^a   Sato, Takahiro ^a   Asano, Tomoichiro ^a,f   Kurihara, Yukiko ^a   Kurihara, Hiroki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Knockout mice; Renal disease; Transcription factor

Indexed keywords

BETA GALACTOSIDASE; PROTEIN TAZ; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWMAN CAPSULE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE INACTIVATION; GENE MUTATION; GLOMERULUS; HOMOZYGOTE; HYDRONEPHROSIS; KIDNEY CONCENTRATING CAPACITY; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; LUNG EMPHYSEMA; MALE; NONHUMAN; POLYURIA; PRIORITY JOURNAL;

EID: 41149112349     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00201.2007     Document Type: Article

References (41)

1. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54: 113-129, 2003.
2. Benezra R. Polycystins: inhibiting the inhibitors. Nat Cell Biol 7: 1064-1065, 2005.
3. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol 13: 26-56, 2006.
4. Chen Q, Takahashi S, Zhong S, Hosoda C, Zheng HY, Ogushi T, Fujimura T, Ohta N, Tanoue A, Tsujimoto G, Kitamura T. Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol 174: 370-374, 2005.
5. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23: 1004-1013, 2003.
6. D'Angelo A, Mioni G, Ossi E, Lupo A, Valvo E, Maschio G. Alterations in renal tubular sodium and water transport in polycystic kidney disease. Clin Nephrol 3: 99-105, 1975.
7. Deen PMT. Mouse models for congenital nephrogenic diabetes insipidus: what can we learn from them? Nephrol Dial Transplant 22: 1023-1026, 2007.
8. Dressler GR. Tubulogenesis in the developing mammalian kidney. Trends Cell Biol 12: 390-395, 2002.
9. Glasser SW, Detmer EA, Ikegami M, Na CL, Stahlman MT, Whitsett JA. Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 278: 14291-14298, 2003.
10. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-F1049, 2003.
11. Gusmano R, Caridi G, Marini M, Perfumo F, Ghiggeri GM, Piaggio G, Ceccherini I, Seri M. Glomerulocystic kidney disease in a family. Nephrol Dial Transplant 17: 813-818, 2002.
12. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364: 709-721, 2004.
13. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078, 2005.
14. Hong JH, Yaffe MB. TAZ: a β-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 5: 176-179, 2006.
15. Horie S. ADPKD: molecular characterization and quest for treatment. Clin Exp Nephrol 9: 282-291, 2005.
16. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, Guo K, Qi Z, Ponniah S, Hong W, Hunziker W. Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc Natl Acad Sci USA 104:1631-1636, 2007.
17. Hu MC, Rosenblum ND. Genetic regulation of branching morphogenesis: lessons learned from loss-of-function phenotypes. Pediatr Res 54: 433-438, 2003.
18. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19: 6778-6791, 2000.
19. Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol 7: 1102-1112, 2005.
20. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 17: 179-181, 1997.
21. Martinez-Maldonado M, Yium JJ, Eknoyan G, Suki WN. Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int 2: 107-113, 1972.
22. McDill BW, Li SZ, Kovach PA, Ding L, Chen F. Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation. Proc Natl Acad Sci USA 103: 6952-6957, 2006.
23. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996.
24. Murakami M, Nakagawa M, Olson EN, Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 102: 18034-18039, 2005.
25. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O, Asano T, Kurihara H. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 339: 533-539, 2006.
26. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual (3rd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2003.
27. Nakagawa O, Nakagawa M, Richardson JA, Olson EN, Srivastava D. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol 216: 72-84, 1999.
28. Nielsen S, Frøkiar J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
29. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schoneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70: 1305-1317, 2002.
30. Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, Zannini M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem 279: 17384-17390, 2004.
31. Shao X, Johnson JE, Richardson JA, Hiesberger T, Igarashi P. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1824-1836, 2002.
32. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894, 1994.
33. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
34. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 95: 752-764, 1967.
35. β-Trcp E3 ligase complex. Mol Cell Biol 27: 6383-6395, 2007.
36. Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat Rev Genet 3: 533-543, 2002.
37. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30: 259-269, 2002.
38. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA. Increased metalloproteinase activity, oxidant production, and emphysema insurfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 97: 5972-5977, 2000.
39. Witzgall R. The proximal tubule phenotype and its disruption in acute renal failure and polycystic kidney disease. Exp Nephrol 7: 15-19, 1999.
40. Yu J, McMahon AP, Valerius MT. Recent genetic studies of mouse kidney development. Curr Opin Genet Dev 14: 550-557, 2004.
41. Zegers MM, O'Brien LE, Yu W, Datta A, Mostov KE. Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol 13: 169 -176, 2003.